Zhang W, Chen Y, Guan Z, Wang Y, Tang M, Du Z
Nat Commun. 2025; 16(1):18.
PMID: 39747008
PMC: 11696373.
DOI: 10.1038/s41467-024-55471-9.
Walker V
Int J Mol Sci. 2024; 25(9).
PMID: 38731904
PMC: 11083860.
DOI: 10.3390/ijms25094684.
Liu Z, Li T, Du Y, Li C, Chong W
Front Nephrol. 2023; 2:935288.
PMID: 37745280
PMC: 10513022.
DOI: 10.3389/fneph.2022.935288.
Portales-Castillo I, Rieg T, Khalid S, Nigwekar S, Neyra J
Adv Kidney Dis Health. 2023; 30(2):177-188.
PMID: 36868732
PMC: 10565570.
DOI: 10.1053/j.akdh.2022.12.011.
Giannini S, Bianchi M, Rendina D, Massoletti P, Lazzerini D, Brandi M
Osteoporos Int. 2021; 32(10):1937-1949.
PMID: 34009447
PMC: 8510985.
DOI: 10.1007/s00198-021-05997-1.
Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis.
Lopez-Sanchez U, Tury S, Nicolas G, Wilson M, Jurici S, Ayrignac X
J Biol Chem. 2020; 295(28):9366-9378.
PMID: 32393577
PMC: 7363132.
DOI: 10.1074/jbc.RA119.011376.
The Causes of Hypo- and Hyperphosphatemia in Humans.
Koumakis E, Cormier C, Roux C, Briot K
Calcif Tissue Int. 2020; 108(1):41-73.
PMID: 32285168
DOI: 10.1007/s00223-020-00664-9.
Phosphate reabsorption in the kidney: NaPi-IIb or not IIb.
Burns D, Werner A
Pflugers Arch. 2020; 472(4):437-438.
PMID: 32236864
PMC: 7165134.
DOI: 10.1007/s00424-020-02374-5.
Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors.
de Paula Colares Neto G, Ide Yamauchi F, Baroni R, Bianchi M, Gomes A, Chammas M
J Endocr Soc. 2019; 3(5):1053-1061.
PMID: 31065622
PMC: 6497922.
DOI: 10.1210/js.2018-00338.
Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report.
Kang S, Lee R, Kim H
Ann Pediatr Endocrinol Metab. 2019; 24(1):64-67.
PMID: 30943683
PMC: 6449619.
DOI: 10.6065/apem.2019.24.1.64.
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.
Kostas M, Haugsten E, Zhen Y, Sorensen V, Szybowska P, Fiorito E
Mol Cell Proteomics. 2018; 17(5):850-870.
PMID: 29371290
PMC: 5930401.
DOI: 10.1074/mcp.RA117.000538.
Genetic Causes of Rickets.
Acar S, Demir K, Shi Y
J Clin Res Pediatr Endocrinol. 2017; 9(Suppl 2):88-105.
PMID: 29280738
PMC: 5790329.
DOI: 10.4274/jcrpe.2017.S008.
A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway.
Wang J, Vogt B, Sethi S, Sampson M, Vega-Warner V, Otto E
Kidney Int Rep. 2017; 2(6):1238-1242.
PMID: 29270533
PMC: 5733768.
DOI: 10.1016/j.ekir.2017.05.006.
X-linked hypophosphatemic rickets (PHEX mutation): A case report and literature review.
Alenazi B, Molla M, Alshaya A, Saleh M
Sudan J Paediatr. 2017; 17(1):61-65.
PMID: 29213174
PMC: 5621863.
An unusual case of hyperphosphatemia in a vitamin D-deficient patient with tuberculosis.
Lee R, Felsenfeld A, Levine B
NDT Plus. 2015; 4(4):264-9.
PMID: 25949499
PMC: 4421439.
DOI: 10.1093/ndtplus/sfr029.
Beneficial effects of growth hormone therapy for ossification defects after bone distraction in X linked hypophosphataemic rickets.
Canete R, Caballero-Villarraso J, Aguilar-Quintero M, Vazquez-Rueda F
BMJ Case Rep. 2014; 2014.
PMID: 25115781
PMC: 4139572.
DOI: 10.1136/bcr-2013-203069.
Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis.
Rajagopal A, Braslavsky D, Lu J, Kleppe S, Clement F, Cassinelli H
J Clin Endocrinol Metab. 2014; 99(11):E2451-6.
PMID: 25050900
PMC: 4223446.
DOI: 10.1210/jc.2014-1517.
[The new WHO classification and recent results in soft tissue tumor pathology].
Petersen I
Pathologe. 2013; 34(5):436-48.
PMID: 23925976
DOI: 10.1007/s00292-013-1784-z.
The changing face of hypophosphatemic disorders in the FGF-23 era.
Lee J, Imel E
Pediatr Endocrinol Rev. 2013; 10 Suppl 2:367-79.
PMID: 23858620
PMC: 4170520.
Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia.
Wu A, Feng B, Chen M, Kolumam G, Zavala-Solorio J, Wyatt S
PLoS One. 2013; 8(2):e57322.
PMID: 23451204
PMC: 3579827.
DOI: 10.1371/journal.pone.0057322.
